Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines

Add time:07/15/2019    Source:sciencedirect.com

Variously substituted 2-hydroxy-N-(arylalkyl)benzamides were prepared and screened for antiproliferative and cytotoxic activity in cancer cell lines in vitro. Five compounds, out of 33 showed single-digit micromolar IC50 values against several human cancer cell lines. One of the most potent compounds N-((R)-1-(4-chlorophenylcarbamoyl)-2-phenylethyl)-5-chloro-2-hydroxybenzamide (6k) reduced proliferation and induced apoptosis in the melanoma cell line G361 in a dose-dependent manner, as shown by decrease in 5-bromo-2′-deoxyuridine incorporation and increase in several apoptotic markers, including subdiploid population increase, activation of caspases and site-specific poly-(ADP-ribose)polymerase (PARP) cleavage.

We also recommend Trading Suppliers and Manufacturers of 4-tert-butyl-N-(propan-2-yl)benzamide (cas 65861-70-3). Pls Click Website Link as below: cas 65861-70-3 suppliers

Prev:New chiral 4-substituted 2-cyanoethyl-oxazolines: Synthesis and assessment of some biological activities
Next:Isolation and structural characterization of 2R, 3R TAXIFOLIN 3-O-RHAMNOSIDE (cas 11027-89-7) from ethyl acetate extract of Hydnocarpus alpina and its hypoglycemic effect by attenuating hepatic key enzymes of glucose metabolism in streptozotocin-induced diabetic rats)